Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Evaluation and Molecular Profiling in Patients With Gastric Tumors

NCT03027427 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT03027427
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03027427 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Evaluation and Molecular Profiling in Patients With Gastric Tumors
Lead sponsor
National Cancer Institute (NCI)
Phase
Observational
Overall status
Completed
Start date
February 1, 2017
Completion date
November 6, 2024
Enrollment
109 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stomach cancer, stomach neoplasms